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Recognition of the existence of bioilm in chronic wounds is increasing among 
wound care practitioners, and a growing body of evidence indicates that bioilm 
contributes signiicantly to wound recalcitrance. While clinical guidelines regarding 
the involvement of bioilm in human bacterial infections have been proposed, 
there remains uncertainty and lack of guidance towards bioilm presence in 
wounds. The intention of this report is to collate knowledge and evidence of the 
visual and indirect clinical indicators of wound bioilm, and propose an algorithm 
designed to facilitate clinical recognition of bioilm and subsequent wound 
management practices.
C
hronic wounds are deined by preven-
tion or delay of the normal wound 
healing process. While underlying eti-
ologies, such as venous insuficiency, 
ischaemia and hypoxia have a major 
impact on wound chronicity, microorganisms can 
also play a signiicant role.1 Recent scientiic stud-
ies have identiied the presence of surface-associat-
ed bacterial communities in the form of bioilm in 
chronic wounds.2-9 Speciically, independent 
research groups in the US2 and Europe3 used spe-
cialist microscopic techniques to examine debride-
ment and biopsy samples; both groups observed 
bioilm microscopically in approximately 60% of 
all chronic wounds. Subsequent in vivo studies 
using a number of controlled animal models have 
conirmed that the presence of bioilm in wounds 
delays healing by interfering with granulation tis-
sue formation, epithelialisation10–13 and host 
defences.14–19 Additionally, case studies and retro-
spective clinical studies in patients have demon-
strated that bioilm-targeting treatment regimes, 
including sharp debridement, antibiotics, cleans-
ers and some antimicrobial dressings, improved 
wound healing outcomes compared to standard 
care.20–23 This body of evidence now strongly sup-
ports the notion that wound bioilm plays a sig-
niicant role in delaying wound healing.24 Moreo-
ver, it is now accepted that bioilm exists in a 
majority of chronic wounds,2–3 is implicated in at 
least 80% of all human bacterial infections,25-26 and 
is a key risk factor for wound infection.27
In the context of wound care, bioilm may be 
deined as communities of microorganisms 
attached to a surface (e.g. wound tissue, wound 
dressings), embedded within a hydrated matrix of 
extracellular polymeric substances (EPS; or slime), 
that provides protection against antimicrobial 
agents and host defenses. EPS is considered to be 
predominantly polysaccharide-based (although 
variable between bacteria),28–30 with protein, lipids 
and DNA also involved.31 In most locations where 
it can develop in the human body (e.g. lungs,32 
indwelling devices,33 catheters34) bioilm is not 
apparent to the naked eye, either due to its internal 
location, or due to its microscopic nature. Howev-
er, in some instances bioilm can exist as a macro-
scopic and visible structure, for example as a dental 
plaque in individuals with poor oral hygiene.35 A 
number of clinicians have recently described what 
they consider to be visible bioilm in chronic 
wounds, in the form of translucent, slimy patches 
or layers,36 or more opaque, green-yellow substance 
on the wound surface.20 This suspected bioilm is 
tolerant to many antimicrobial interventions and 
can re-form quickly after debridement unless man-
aged with effective antimicrobial agents and appro-
priate dressing technologies.20–21 Following debri-
dement, exposed bacteria remaining in the wound 
can re-establish bioilm quickly, often within 24 
hours,20 in order to evade host responses and anti-
microbial therapies.37 This is in contrast to devital-
ised host tissue such as slough or ibrin which is 
much slower to re-form,20 but can itself be a sub-
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strate for bioi lm formation. Whereas bioi lm on 
the wound surface may be reasonably easy to 
remove atraumatically using debridement meth-
ods such as swabs, fabric pads or curettage, slough 
is more contiguous with the underlying wound tis-
sue and can be more difi cult to remove.20–21 In 
addition, proteinaceous, devitalised host tissue 
may be more responsive to enzymatic or autolytic 
debridement than the complex EPS of bioi lm,20 
which may be a way to distinguish between slough 
and bioi lm.
Identi cation of bio lm
Whether the material frequently observed by clini-
cians is actually bioi lm rather than slough, i brin 
or a combination of devitalised host tissue and 
bioi lm is the subject of debate in the scientii c and 
clinical communities.38–41 In the absence of a rou-
tine test for the presence and location of wound 
bioi lm,42 this distinction is difi cult to coni rm. 
Recently, there have been calls for point-of-care 
wound bioi lm detection methods,25,39,41 which, in 
the future may be useful to guide effective wound 
bed preparation and dressing selection. In our own 
laboratories, we have demonstrated how bioi lm 
cultured in vitro can be rapidly and specii cally 
stained. Using a membrane i lter substrate,43 bio-
i lm of a  uorescent strain of Pseudomonas aerugi-
nosa was cultured. The bioi lm was then stained 
with a photosensitive dye, based on dental plaque 
disclosing agents, that stains EPS and bacteria and 
 uoresces at a different wavelength to the bacterial 
 uorescence. This allowed imaging of the bioi lm 
(Figure 1A) and dye location (Figure 1B) separately, 
by confocal laser scanning microscopy (CLSM). By 
overlaying these images, the intimate correlation 
between the bioi lm bacteria, surrounding EPS and 
the dye was apparent (Figure 1C), coni rming that 
Table 1. Indirect clinical indications of wound bioi lm by routine clinical assessment. 
Clinical observation Clinical and scientii c commentary
Excessive moisture Bacteria thrive in a moist environment; excessive moisture is likely to encourage bio lm 
development.21
Poor-quality granulation tissue e.g. friable, 
hypergranular
Bio lm may be implicated in friable granulation tissue that has been associated with wound 
infection.44
Signs of local infection (redness, heat, swelling, 
pain, odour)
Bio lm is a precursor to infection,27 and may trigger early warning signs of infection.
History of antibiotic failure or persistent or 
recurring infection, despite choice of 
antimicrobial therapy
Bio lm bacteria often evade the action of antibiotics. In the event of antibiotic success, 
return of an infection following cessation of antibiotics is a sign of continued bio lm 
presence.25 Bio lm may contain populations of bacterial persister cells that can survive 
antimicrobial therapies. They may re-emerge once therapy ceases, acting as seeding agents 
and recruiters for subsequent bio lm re-formation.45
Culture-negative results despite signs of 
bacterial colonisation or a high suspicion of 
clinical infection
Bio lm bacteria metabolise more slowly, reproduce less frequently and show different traits 
(phenotypes) than planktonic bacteria, and standard microbiological culture techniques are 
incapable of identifying all species present in wound samples.46 As a result, wound bio lm 
bacteria are often dif cult or impossible to culture.47
Wound remains recalcitrant even though all 
obvious underlying comorbidities have also 
been addressed
There is another factor keeping the wound in a chronic state, and this factor, even though it 
is not always visible, may be bio lm.
Fig 1. CLSM images of  uorescent Pseudomonas aeruginosa  bioi lm cultured on membrane i lters.43 (A) 
Fluorescence of the bioi lm bacteria. (B) Fluorescence of the dye that stains EPS and bacteria. (C) 
Fluorescence images of (A) and (B) overlaid.
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the uorescent dye was capable of staining bio-
ilm. The technique of uorescence detection 
offers one potential route towards a point-of-care 
wound bioilm detection method, perhaps using a 
bioilm stain and a hand-held inspection device. 
Such a device could be used to inspect wounds for 
bioilm to aid effective debridement and cleansing 
and to monitor wound status over time, although 
this might be limited to detecting surface-associat-
ed bioilm rather than any invasive, sub-surface 
bioilm.
However, even in the absence of a point-of-care 
bioilm visualisation technique, it is possible to 
compile clinical indicators and conditions that can 
facilitate judgement on the presence or absence of 
wound bioilm, based on current understanding of 
bioilm formation, composition, appearance, 
behaviour and treatment strategies. The intention 
of the current work is to consider ways in which 
wounds can be assessed for bioilm, and to propose 
a clinical algorithm that is designed to help clini-
cians to determine the presence of bioilm. 
Visual indicators of wound biolm
In some established chronic wounds, bioilm for-
mation may progress to a stage where it is macro-
scopic and visible to the experienced naked eye. 
For example, a shiny, translucent substance on the 
surface of the wound (Fig 2A) may be indicative of 
thin but observable bioilm, careful debridement 
of which may reveal a healthier wound bed.20 At 
this stage, the wound may be cleansed and covered 
with an appropriate dressing that minimises the 
opportunity for remaining bacteria to re-form bio-
ilm. Wound bioilm may also present as opaque, 
loosely-attached patches in some parts of the 
wound (Fig 2B), that can be carefully and atrau-
matically dislodged using standard debridement 
methods.21 Viscous, slimy or gel-like substances 
can form on, beneath or even within some dress-
ings (Fig 2C), including some antimicrobial dress-
ings (Fig 2D). In some instances, the proliferation 
of certain bacterial species can result in the secre-
tion of pigments, and in the case of two common 
wound-associated pathogens, Pseudomonas aerugi-
Fig 2. Visual indicators of wound bioilm; (A) a static, non-progressing wound on a stable diabetic patient that had amputation of 
four toes. The shiny appearance of parts of the wound bed may be bioilm (as indicated by arrows); (B) a stage IV pressure ulcer 
with a heavily colonised wound bed. There may be a layer of suspected bioilm over some of the wound bed, particularly on the right 
side of the wound where this substance appears to be slightly thicker and opaque (as indicated by arrow); (C) an ischaemic and 
infected wound with suspected bioilm forming through and over a previously-applied gauze dressing; (D) green-pigmented 
suspected bioilm formed within 24 hours in a chronic wound beneath, and on, a silver alginate dressing; (E) forefoot amputation 
with bone exposure. Viscous, pale, green-blue, slimy suspected bioilm covered most of the wound bed; (F) surgical wound, post-
necrotising fasciitis. The subsequent skin graft failed to take, and the wound had been static with minimal progress. The wound 
surface exhibited yellow suspected bioilm, possibly mixed with slough, with granulation tissue attempting to form beneath; (G) an 
ischaemic wound exhibiting signs of infection. This suspected bioilm re-formed quickly over granulation tissue despite antibiotic 
usage; (H) the suspected bioilm could be removed atraumatically using forceps to reveal the granulation tissue beneath.
A B C D
E F G H
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1. Does the surface substance detach easily and 
atraumatically from the underlying would bed using 
physical removed techniques such as swabs, pads or sharp 
debridement?
4. Does the wound respond poorly to topical or systemic 
antibiotics?
2. Does the surface substance persist despite use of 
autolytic or enzymatic debridement?
5. Does the wound respond poorly or slowly to dressings 
than contain antiseptic agents (e.g. silver, iodine, PHMB), 
including products that may control biolm in vitro (e.g., 
cadexomer iodine, nanocrystalline silver or ionic silver 
containing carboxymethyl cellulose dressings)?
3. Does the surface substance re-form quickly (in 1-2 
days) in the absence of frequent intervention (e.g. 
cleansing, debridement)?
6. Does the wound respond favourably to multi-modal 
strategies such as physical debridement, cleansing, and 


























Fig 3. Clinical algorithm for wound bioilm identiication.
nosa and Staphylococcus aureus, this may result in 
pale green or pale yellow bioilm, due to the pro-
duction of pyocyanin (green-blue; Figure 2E) or 
staphyloxanthin (golden; Figure 2F), respectively. 
However, this coloured substance may be dificult 
to visibly distinguish from slough. While it may 
resemble host devitalised tissue, it behaves differ-
ently than slough or ibrin in that it can be more 
easily removed but re-forms quickly – a key indica-
tive sign of wound bioilm. This substance may lie 
on the wound surface, rather than being contigu-
ous with the underlying wound tissue (Figure 2G), 
and may be carefully removed, for example by for-
ceps, to reveal cleaner granulation tissue beneath 
(Figure 2H).
Indirect clinical indicators of biolm
In many instances where wound bioilm is not 
clearly distinguishable to the experienced naked 
eye, other clinical cues may indicate the presence of 
bioilm. Table 1 summarises some of these indirect 
clinical indicators of bioilm presence which should 
be considered during routine clinical assessment.
A clinical algorithm
By combining the above visual (Fig 2) and indirect 
indicators of wound bioilm (Table 1), an algorithm 
is proposed that may assist clinicians in conirming 
wound bioilm and subsequently taking appropri-
ate measures to manage it (Fig 3). This algorithm 
poses questions around the appearance of sub-
stances in the wound and their response to wound 
bed preparation techniques, then considers the 
wound’s behaviour to antimicrobial agents. It may 
be started at question 1 or question 4, depending 
on the appearance of the wound. This algorithm 
may thus facilitate clinical judgement of the likely 
substances involved (e.g. bioilm – viable, bacteria-
derived tissue; slough – non-viable, host tissue) 
and the predominant mode of bacterial existence 
(i.e. bioilm or planktonic). This algorithm is con-
cerned with local wound factors and should be 
considered only once other, endogenous patho-
physiological factors, e.g. hypoxia or ischaemia, 
and external factors, e.g. pressure or lifestyle, have 
been addressed and minimised. With an increasing 
number of afirmative answers in the algorithm, 
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there will be a likewise increase in the probability 
of bioilm presence and its involvement in wound 
recalcitrance.
Conclusion
Through a review of the literature and our current 
understanding of wound bioilm, it has been possi-
ble to collate a variety of visual indicators that may 
directly indicate the presence of bioilm, together 
with other indirect clinical indicators, which have 
collectively enabled the development of a clinical 
algorithm for wound bioilm presence. While much-
needed wound bioilm research and guidance is 
being published at a great pace,48 this algorithm will 
hopefully facilitate clinical recognition of bioilm 
and subsequent optimal wound management. 
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Broj publiciranih referenci koje ukazuju na prisutnost biofi lma u kroničnim ranama je u porastu. Sve je veći broj dokaza 
koji potvrđuju da biofi lm značajno sudjeluje u nezacijeljivanju rane i u bakterijskim infekcijama. Iz navedenih razloga 
postavlja se pitanje nedostatka postupnika o dokazima prisutnosti biofi lma u rani. Namjera je ovog rada specifi cirati vidljive 
dokaze i indirektno dati kliničke smjernice tretmana biofi lma u rani, te predložiti određeni postupnik za olakšanje kliničkog 
prepoznavanja biofi lma da bi se potom promijenilo ciljano liječenje vrijeda.
Ključne riječi: biofi lm rane; prepoznavanje; postupnik; klinička procjena
Ovaj je postupnik pretisak rada iz časopisa Journal of Wound Care 2014; 23(3) s dozvolom od 10. veljače 2016. godine.
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